Miguel Gómez Álvarez and Carlos Vallejo/X
Jun 12, 2026, 16:12
Miguel Gómez Álvarez: The Evidence on Disease Burden in PNH
Miguel Gómez Álvarez, Hematologist at Department of Hematology and Hemotherapy, Hospital Clínico San Carlos, Madrid, Spain, shared a post on X:
“Carlos Vallejo presents the evidence on the disease burden in PNH:
The importance of fatigue in patients already treated with iC5, the impact on quality of life, and the relevance of shared decision-making.”
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community
-
Sep 19, 2026, 10:46Anton Farkas: Mechanical Thrombectomy for Acute PE in Early Pregnancy
-
Sep 19, 2026, 10:40Marjolein Smidt: ASH Raises Ferritin Thresholds for Iron Deficiency
-
Sep 19, 2026, 10:34Nawsherwan Mohammad: ASH 2026 Guidelines Redefine How We Detect Iron Deficiency